194 related articles for article (PubMed ID: 2959886)
1. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels.
MacRae PG; Spirduso WW; Cartee GD; Farrar RP; Wilcox RE
Neurosci Lett; 1987 Aug; 79(1-2):138-44. PubMed ID: 2959886
[TBL] [Abstract][Full Text] [Related]
2. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.
MacRae PG; Spirduso WW; Walters TJ; Farrar RP; Wilcox RE
Psychopharmacology (Berl); 1987; 92(2):236-40. PubMed ID: 3110847
[TBL] [Abstract][Full Text] [Related]
3. Modulation of activity of the striatal dopaminergic system during the hibernation cycle.
Kilduff TS; Bowersox SS; Faull KF; Zeller-DeAmicis L; Radeke CM; Ciaranello RD; Heller HC; Barchas JD; Dement WC
J Neurosci; 1987 Sep; 7(9):2732-6. PubMed ID: 3625271
[TBL] [Abstract][Full Text] [Related]
4. Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
Falardeau P; Bédard PJ; Di Paolo T
Neurosci Lett; 1988 Mar; 86(2):225-9. PubMed ID: 2966905
[TBL] [Abstract][Full Text] [Related]
5. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol.
Lévesque D; Di Paolo T
Neurosci Lett; 1988 May; 88(1):113-8. PubMed ID: 2969467
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
7. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
8. Characterization of D2 receptors and dopamine levels in the thalamus of the rat.
Young KA; Wilcox RE
Life Sci; 1991; 48(19):1845-52. PubMed ID: 1645835
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
10. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
Leslie CA; Bennett JP
Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
[TBL] [Abstract][Full Text] [Related]
11. 3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.
Werle E; Lenz T; Strobel G; Weicker H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):28-34. PubMed ID: 2853303
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
Hruska RE
J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
[TBL] [Abstract][Full Text] [Related]
13. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
Mjörndal T; Persson SA
Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
[TBL] [Abstract][Full Text] [Related]
14. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
Wong DT; Threlkeld PG; Bymaster FP
Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
[TBL] [Abstract][Full Text] [Related]
16. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
[TBL] [Abstract][Full Text] [Related]
17. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
Urwyler S; Coward D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
Panagopoulos NT; Matsokis NA; Valcana T
J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
[TBL] [Abstract][Full Text] [Related]
19. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
Hirata H; Ogawa N; Asanuma M; Ota Z; Mori A
Brain Res; 1993 Feb; 604(1-2):197-204. PubMed ID: 8457848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
